A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes
Crossref DOI link: https://doi.org/10.1007/s12185-015-1862-5
Published Online: 2015-09-01
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jang, Jun Ho
Harada, Hironori
Shibayama, Hirohiko
Shimazaki, Ryutaro
Kim, Hyeoung-Joon
Sawada, Kenichi
Mitani, Kinuko
Funding for this research was provided by:
Kyowa Hakko Kirin
Text and Data Mining valid from 2015-09-01